Indication · Cardiology
Varicose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
41
Cleared or approved since 2000
PMA and De Novo
7
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
31
336 device trials in all
Devices
34 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- PhasTIPP
LeMaitre Vascular, Inc. · 510(k) · Stripper, Vein, External · newest 2022
33 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUsPivotal-lookingNot yet recruiting
StimLabsNot on our public-company list
NCT07449988 · 272 participants (planned) · Start Apr 2027 · Primary completion Dec 2029
Device: Corplex P; Theracor · For: Venous Leg Ulcers; Venous Leg Ulcers (VLUs); Venous Leg and 2 more
335 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on varicose veins across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.